|
1
|
Lu Y, Boss JM, Hu SX, Xu HJ and Blanck G:
Apoptosis-independent retinoblastoma protein rescue of HLA class II
messenger RNA IFN-gamma inducibility in non-small cell lung
carcinoma cells. Lack of surface class II expression associated
with a specific defect in HLA-DRA induction. J Immunol.
156:2495–2502. 1996.PubMed/NCBI
|
|
2
|
Blanck G: Components of the IFN-gamma
signaling pathway in tumorigenesis. Arch Immunol Ther Exp (Warsz).
50:151–158. 2002.PubMed/NCBI
|
|
3
|
Xi H, Eason DD, Ghosh D, Dovhey S, Wright
KL and Blanck G: Co-occupancy of the interferon regulatory element
of the class II transactivator (CIITA) type IV promoter by
interferon regulatory factors 1 and 2. Oncogene. 18:5889–5903.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lu Y, Ussery GD, Muncaster MM, Gallie BL
and Blanck G: Evidence for retinoblastoma protein (RB) dependent
and independent IFN-gamma responses: RB coordinately rescues
IFN-gamma induction of MHC class II gene transcription in
noninducible breast carcinoma cells. Oncogene. 9:1015–1019.
1994.PubMed/NCBI
|
|
5
|
Lu Y, Tschickardt ME, Schmidt BJ and
Blanck G: IFN-gamma inducibility of class II transactivator is
specifically lacking in human tumour lines: Relevance to
retinoblastoma protein rescue of IFN-gamma inducibility of the HLA
class II genes. Immunol Cell Biol. 75:325–332. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Xi H, Goodwin B, Shepherd AT and Blanck G:
Impaired class II transactivator expression in mice lacking
interferon regulatory factor-2. Oncogene. 20:4219–4227. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Xi H and Blanck G: Interferon regulatory
factor-2 point mutations in human pancreatic tumors. Int J Cancer.
87:803–808. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Eason DD, Coppola D, Livingston S,
Shepherd AT and Blanck G: Loss of MHC class II inducibility in
hyperplastic tissue in Rb-defective mice. Cancer Lett. 171:209–214.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhu X, Pattenden S and Bremner R: pRB is
required for interferon-gamma-induction of the MHC class II abeta
gene. Oncogene. 18:4940–4947. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Osborne A, Zhang H, Yang WM, Seto E and
Blanck G: Histone deacetylase activity represses gamma
interferon-inducible HLA-DR gene expression following the
establishment of a DNase I-hypersensitive chromatin conformation.
Mol Cell Biol. 21:6495–6506. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Osborne AR, Zhang H, Fejer G, Palubin KM,
Niesen MI and Blanck G: Oct-1 maintains an intermediate, stable
state of HLA-DRA promoter repression in Rb-defective cells: An
Oct-1-containing repressosome that prevents NF-Y binding to the
HLA-DRA promoter. J Biol Chem. 279:28911–28919. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chornoguz O, Gapeev A, O'Neill MC and
Ostrand-Rosenberg S: Major histocompatibility complex class II+
invariant chain negative breast cancer cells present unique
peptides that activate tumor-specific T cells from breast cancer
patients. Mol Cell Proteomics. 11:1457–1467. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Srivastava MK, Bosch JJ, Wilson AL,
Edelman MJ and Ostrand-Rosenberg S: MHC II lung cancer vaccines
prime and boost tumor-specific CD4+ T cells that cross-react with
multiple histologic subtypes of nonsmall cell lung cancer cells.
Int J Cancer. 127:2612–2621. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Truman JP, Choqueux C, Charron D and
Mooney N: HLA class II molecule signal transduction leads to either
apoptosis or activation via two different pathways. Cell Immunol.
172:149–157. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Le E, Zhang H and Blanck G: CIITA
transformation rescues the apoptotic function of MHC class II in
melanoma cells. Anticancer Res. 25:3889–3892. 2005.PubMed/NCBI
|
|
16
|
Stoll RJ, Thompson GR, Samy MD and Blanck
G: De novo, systemic, deleterious amino acid substitutions are
common in large cytoskeleton-related protein coding regions. Biomed
Rep. 6:211–216. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Choi Y, Sims GE, Murphy S, Miller JR and
Chan AP: Predicting the functional effect of amino acid
substitutions and indels. PLoS One. 7:e466882012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yun S, Vincelette ND, Green MR, Wahner
Hendrickson AE and Abraham I: Targeting immune checkpoints in
unresectable metastatic cutaneous melanoma: A systematic review and
meta-analysis of anti-CTLA-4 and anti-PD-1 agents trials. Cancer
Med. 5:1481–1491. 2016. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Khawar MB, Abbasi MH and Sheikh N: IL-32:
A novel pluripotent inflammatory interleukin, towards gastric
inflammation, gastric cancer, and chronic rhino sinusitis.
Mediators Inflamm. 2016:84137682016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Fornaro R, Caratto M, Caratto E, Caristo
G, Fornaro F, Giovinazzo D, Sticchi C, Casaccia M and Andorno E:
Colorectal cancer in patients with inflammatory bowel disease: The
need for a real surveillance program. Clin Colorectal Cancer.
15:204–212. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Macián F, Im SH, García-Cózar FJ and Rao
A: T-cell anergy. Curr Opin Immunol. 16:209–216. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kohlmeier JE, Chan MA and Benedict SH:
Costimulation of naive human CD4 T cells through intercellular
adhesion molecule-1 promotes differentiation to a memory phenotype
that is not strictly the result of multiple rounds of cell
division. Immunology. 118:549–558. 2006.PubMed/NCBI
|
|
23
|
Lugini L, Matarrese P, Tinari A, Lozupone
F, Federici C, Iessi E, Gentile M, Luciani F, Parmiani G, Rivoltini
L, et al: Cannibalism of live lymphocytes by human metastatic but
not primary melanoma cells. Cancer Res. 66:3629–3638. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lloyd MC, Szekeres K, Brown JS and Blanck
G: Class II transactivator expression in melanoma cells facilitates
T-cell engulfment. Anticancer Res. 35:25–29. 2015.PubMed/NCBI
|
